Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Seres Therapeutics Inc
F:1S90
Seres Therapeutics Inc
F:1S90
Price:
1.606
EUR
-13.75%
Market Cap:
€14.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Seres Therapeutics Inc
F:1S90
|
US |
|
Logista Integral SA
F:5CI
|
ES |
|
QYOU Media Inc
F:0QY0
|
CA |
|
Z
|
Zurich Insurance Group AG
DUS:ZFIN
|
CH |
|
L
|
Leonardo SpA
XHAM:FMNB
|
IT |
Wall St Price Targets
1S90 Price Forecast
Based on 4 analysts
Based on 4 analysts
+776% Upside
from
€1.606
today
Seres Therapeutics Inc (1S90)’s 12-month stock price forecast through October 2027 has a consensus target of €14.065, implying 776% upside. The forecast is based on price targets from 4 Wall Street analysts.
1S90 Analyst Rating
No ratings yet
No ratings yet
Seres Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1S90's stock price target?
Price Target
14.065
EUR
14.065
EUR
According to Wall Street analysts, the average 1-year price target for 1S90 is 14.065 EUR with a low forecast of 9.831 EUR and a high forecast of 18.737 EUR.
What is the Revenue forecast for Seres Therapeutics Inc?
Projected CAGR
-7%
-7%
The compound annual growth rate for Revenue over the next 5 years is -7%.